These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 5632093

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Hypothalamic lesions in goldthioglucose injected mice.
    MARSHALL NB, BARRNETT RJ, MAYER J.
    Proc Soc Exp Biol Med; 1955 Oct; 90(1):240-4. PubMed ID: 13273410
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Ultrastructural study of the hypothalamic region after administration of aurothioglucose in mice].
    Skarda R, Marcaník J, Belák M.
    Vet Med (Praha); 1977 Oct; 22(10):621-7. PubMed ID: 414410
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Reserpine prevents goldthioglucose hypothalamic lesions in mice.
    Briese E, Murzi E.
    Experientia; 1981 Jan 15; 37(1):52-3. PubMed ID: 6781929
    [Abstract] [Full Text] [Related]

  • 29. Gold-thioglucose-induced hypothalamic lesions inhibit metabolic modulation of light-induced circadian phase shifts in mice.
    Challet E, Bernard DJ, Turek FW.
    Brain Res; 1999 Apr 03; 824(1):18-27. PubMed ID: 10095038
    [Abstract] [Full Text] [Related]

  • 30. Quantitative relationships between food intake, lipid deposition and hypothalamic damage in goldthioglucose obesity.
    McBurney PL, Liebelt RA, Perry JH.
    Tex Rep Biol Med; 1965 Apr 03; 23(4):737-52. PubMed ID: 5886404
    [No Abstract] [Full Text] [Related]

  • 31. [Studies on the brain lesions induced by goldthioglucose in mice].
    Mori A.
    Seishin Shinkeigaku Zasshi; 1966 Nov 03; 68(11):1310-23. PubMed ID: 6009635
    [No Abstract] [Full Text] [Related]

  • 32. Factors influencing the lesioning effect of gold thioglucose on the ventromedial hypothalamus of Bar Harbor obese mice.
    McLaughlin CL, Baile CA, Trueheart PA, Mayer J.
    Physiol Behav; 1973 Feb 03; 10(2):339-43. PubMed ID: 4575309
    [No Abstract] [Full Text] [Related]

  • 33. Diabetes-induced resistance of ventromedial hypothalamus to damage by gold thioglucose: reversal by adrenalectomy.
    Debons AF, Krimsky I, From A, Pattinian H.
    Endocrinology; 1974 Dec 03; 95(6):1636-41. PubMed ID: 4611746
    [No Abstract] [Full Text] [Related]

  • 34. Gold thioglucose induced terminal degeneration in mouse hypothalamus.
    Záborszky L, Léránth C, Palkovits M.
    Experientia; 1974 Jul 15; 30(7):811-4. PubMed ID: 4211238
    [No Abstract] [Full Text] [Related]

  • 35. Hypothalamic glucoreceptors--the influence of thioglucose implants in the ventromedial and lateral hypothalamic areas of normal and diabetic rats.
    Smith CJ.
    Physiol Behav; 1972 Sep 15; 9(3):391-6. PubMed ID: 4572433
    [No Abstract] [Full Text] [Related]

  • 36. [Development of intracranial osteomas in mice injected with gold thioglucose].
    Rudali G.
    Rev Fr Etud Clin Biol; 1968 Jan 15; 13(1):40-8. PubMed ID: 5653555
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.